Skip to content

Clinical trials

Phase 2 Graft vs Host Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 2 Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20131
20151
20161
20171
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma2
Mallinckrodt2
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH1
Jazz Pharmaceuticals1
Prof. Dr. Nikolas von Bubnoff1
Syndax Pharmaceuticals1
University of Cologne1
VectivBio AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease10
Hematologic Neoplasms2
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Bronchiolitis Obliterans Syndrome1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1
Lymphoma, T-Cell, Peripheral1
Recurrence1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.